TYRA BIOSCIENCES, INC.
TYRA
20.12
+0.39
+1.98%
TYRA BIOSCIENCES, INC.
US · TYRA
#3032 by market cap
Listed 2021
20.12
+0.39
+1.98%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Tyra Biosciences Price Target Cut to $29.00/Share From $30.00 by HC Wainwright & Co.Dow Jones · 2026/9/22
-
Company notice
TYRA BIOSCIENCES, INC. | SCHEDULE 13G: OthersSEC · 2026/9/22
-
Company notice
TYRA BIOSCIENCES, INC. | SCHEDULE 13G/A: OthersSEC · 2026/10/28
-
Rating change
A Quick Look at Today's Ratings for TYRA BIOSCIENCES, INC.(TYRA.US), With a Forecast Between $39 to $56Market Newswire · 2026/9/8
-
Rating change
Barclays Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $59Market Newswire · 2026/10/26
-
JonesTrading Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $56Market Newswire · 2026/11/14
-
Company notice
TYRA BIOSCIENCES, INC. | 10-Q: Quarterly reportSEC · 2026/11/10
-
Rating change
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $40Market Newswire · 2026/9/22
-
Rating change
A Quick Look at Today's Ratings for TYRA BIOSCIENCES, INC.(TYRA.US), With a Forecast Between $30 to $59Market Newswire · 2026/9/10
-
A Quick Look at Today's Ratings for TYRA BIOSCIENCES, INC.(TYRA.US), With a Forecast Between $27 to $59Market Newswire · 2026/11/12
-
Company notice
TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Officer Harris ToddSEC · 2026/9/18
-
Rating change
CCORF Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/10/20
-
Earnings Flash (TYRA) Tyra Biosciences Posts Q3 Net Loss $0.74 a Share, Vs. FactSet Est of $0.67 LossMT Newswires · 2026/11/10
-
Rating change
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30Benzinga · 2026/9/10
-
Rating change
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29Benzinga · 2026/9/22
-
Rating change
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $29Market Newswire · 2026/9/22
-
Company notice
TYRA BIOSCIENCES, INC. | 8-K: Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recent HighlightsSEC · 2026/11/10
-
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $27Market Newswire · 2026/11/11
-
Rating change
Raymond James Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $50Market Newswire · 2026/9/24
-
Rating change
Jefferies Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $42Market Newswire · 2026/8/6
-
Rating change
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/9/4
-
Rating change
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $39Market Newswire · 2026/8/11
-
Rating change
JonesTrading Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $56Market Newswire · 2026/9/10
-
Company notice
TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Officer Rueb YuliyaSEC · 2026/9/18
-
Rating change
Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $53Market Newswire · 2026/8/5
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
TYRA BIOSCIENCES, INC. discussion 0 comments